The ASAM Board Examination Study Tool (BEST) helps prepare physicians for the ABPM certification/re-certification examination utilizing an interactive and engaging format.
This powerful study tool includes:
- Bank of 600 self-assessment questions reviewed for accuracy by addiction medicine experts
- Content derived from the ABPM Exam Blueprint for effective study guidance
- Excerpts and highlights from ASAM’s Essentials of Addiction Medicine and Principles of Addiction Medicine
- Glossary of important terms and definitions
- Additional resources recommended by Review Course faculty and experts for each topic
- 12 CME Credits upon completion
- Fully searchable functionality and content
- Access to the BEST 24/7 online at ASAM's e-Learning Center
Live attendees of the 2018 ASAM Review Course in Addiction Medicine in Dallas, TX receive the 2018 BEST complimentary with registration.
Goals and Objectives
Upon completion of this education activity, participant should be able to:
- Differentiate between important terms and definitions in the field of Addiction Medicine.
- Distill knowledge on key points from the text, the Principles of Addiction Medicine, 5th edition and course slides
- Appraise addiction patient cases and respond accurately to questions about next steps and treatment options.
- Employ knowledge gained in the educational sections of the BEST to respond accurately to self-assessment questions.
Participants of the 2018 ASAM Review Course in Addiction Medicine and other physicians who are preparing for the ABPM Certification Exam in Addiction Medicine.
ACCME Accreditation Statement
The American Society of Addiction Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
AMA Credit Designation Statement
The American Society of Addiction Medicine designates this enduring material for a maximum of 12 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
|First Name||Commercial Interests||Compensation Received||For what Role?|
|Timothy Brennan MD, MPH, FASAM||None|
|Jeffrey DeVido MD||Altria/Philip Morris||Stock||Inheritance|
|Paul Earley MD, DFASAM||Alkermes, Inc; DynamiCare Health, Inc||honoraria; Salary||Speaker; VP of Medical Affairs|
|James Finch MD, DFASAM||None|
|Marc Fishman MD, DFASAM||US World Meds; Alkermes||consulting fee, travel; honoraria||Consultant; Advisory board|
|David Galbis-Reig MD, DFASAM||Ascension Wisconsin All Saints; Abbvie; Hospira; RespireRX Pharmaceuticals; Abbott Pharmaceuticals; Pfizer Bond||Stock& Bond in Retirement IRA; Stock Options; Ownership Interests||Owner; Advisory board; PI; Consultant|
|R. Jeffrey Goldsmith, MD, DLFAPA, DFASAM||None|
|Adam Gordon, MD, MPH||None|
|Leslie Hayes, MD||None|
|Abigail Herron DO, DFASAM||None|
|Petros Levounis MD, MA, FASAM||None|
|Carla Marienfeld MD||None|
|Ricardo Restrepo MD, MPH, FASAM||None|
|Richard Ries MD, DFASAM||None|
|Edwin Salsitz MD, DFASAM||None|
|Sharon Stancliff MD, FASAM||None|
|Timothy Wiegand MD, FACMT, FAACT||None|
|Erin Zerbo, MD||None|